Skip to main content
Premium Trial:

Request an Annual Quote

AutoGenomics Pockets $12M in VC Cash; Will Expand Manufacturing, S&M

NEW YORK (GenomeWeb News) — AutoGenomics has hauled in $12 million through a Series C round of private-equity financing from non-institutional investors, the company said today.
 
President Fareed Kureshy said the company will use the cash to “extend our test application menu, expand manufacturing and increase our sales and marketing efforts” for its Infiniti film-based microarray system.
 
The assays are designed to help diagnose clotting disorder thrombophilia.
 
Kureshy said the company does not expect to require more funding for continued growth because its coagulation Factor II and V in vitro diagnostic tests and its analyzer were recently cleared by the US Food and Drug Administration.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more